Communications network W20 Group has acquired digital marketing firm Marketeching Solutions.
Financial terms of the deal were not publicly disclosed.
![]() |
Marketeching is a healthcare-focused consultancy that partners with brand marketers and market researchers to offer insights and analytics that enhance strategy. The New Hope, PA-based company, which employs about 20, maintains a second office in Philadelphia. The company was founded in 2008 by Kevin Johnson, who serves as President.
![]() |
“We acquired Marketeching to accelerate growth and further deepen and broaden our expertise in analytics focused on healthcare and life sciences,” W20 Group chairman and CEO Jim Weiss told O’Dwyer’s. “These core areas continue to increase in importance as the landscape changes rapidly with the advent of new technologies, consumer choice, regulations and cost/access headwinds that are likely to get even stronger after this election.”
Marketeching will now become an independent subsidiary of W2O Group. It will continue to be run by Johnson, who maintains the president title. He’ll report to Paul Dyer, president of W2O’s Analytics and Insights practice.
W20, which focuses on tech and global brands and owns agencies Brewlife, Twist Mktg and WCG, in September acquired Wilmington, NC-based life sciences PR agency Pure Communications.



To negotiate the demands of media, investors, regulators and the market, communicators to make sure that their narrative they construct is defensible every stop of the way.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.



